Valuation (69%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -16.93 | N/A |
PEG Ratio (TTM) | 0.02 | N/A |
P/S Ratio (TTM) | 0.30 | N/A |
P/B Ratio (TTM) | -2.23 | N/A |
P/FCF Ratio (TTM) | 6.57 | N/A |
Price to 5YR AVG Earnings Ratio | 5.69 | N/A |
Price to 5YR AVG FCF Ratio | 6.91 | N/A |
Profitability (30%) |
Company | Industry |
---|---|---|
ROA (TTM) | -2.23% | N/A |
ROE (TTM) | 12.07% | N/A |
Net Profit Margin (TTM) | -1.76% | N/A |
ROIC 5YR AVG | 31.73% | N/A |
Growth (80%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -41.93% | 2,734.57% | 1,586.90% |
Revenue | 30.12% | 18.96% | 8.29% |
Net Income | -42.05% | 2,794.62% | 1,623.03% |
Cash Flow | 71.11% | 27.37% | 310.56% |
Health (37%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.71 | N/A |
Quick Ratio (TTM) | 0.76 | N/A |
D/E Ratio (TTM) | -1.58 | N/A |
Interest Coverage (TTM) | 0.81 | N/A |
Piotroski F-Score | 3 | N/A |
Altman Z-Score | 1.46 | N/A |
LTL to 5YR AVG FCF | 3.65 | N/A |
Shares Outstanding Growth 5YR AVG | -0.21% | N/A |